Tech Company Financing Transactions
Immune Control Funding Round
Immune Control, operating out of West Conshohocken, secured $6 million in funding from Domain Associates, NewSpring Capital and private investors.
Transaction Overview
Company Name
Announced On
6/30/2008
Transaction Type
Venture Equity
Amount
$6,004,000
Round
Undisclosed
Investors
Domain Associates (Brian Halak)
NewSpring Capital (Zev Scherl)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
200 Barr Harbor Drive 450
West Conshohocken, PA 19428
USA
West Conshohocken, PA 19428
USA
Phone
Website
Email Address
Overview
Immune Control, Inc. is a pharmaceutical company developing compounds for treatment of multiple myeloma and other immunological diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Strobeck
VP - Finance
Anne Shiflett
Browse more venture capital transactions:
Prev: 6/30/2008: Lithium Technologies venture capital transaction
Next: 6/30/2008: Ampla Pharmaceuticals venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs